Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $2.8 million.

  • Therapeutics' Amortizatization of Intangibles fell 56.70% to $530,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year decrease of 50.96%. This contributed to the annual value of $2.8 million for FY2024, which is 50.96% down from last year.
  • Latest data reveals that Therapeutics reported Amortizatization of Intangibles of $2.8 million as of FY2024, which was down 50.96% from $5.7 million recorded in FY2023.
  • Therapeutics' Amortizatization of Intangibles' 5-year high stood at $5.7 million during FY2023, with a 5-year trough of -$1.3 million in FY2021.
  • Over the past 3 years, Therapeutics' median Amortizatization of Intangibles value was $2.8 million (recorded in 2024), while the average stood at $2.9 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first plummeted by 355.53% in 2021, then surged by 1,837.84% in 2023.
  • Over the past 5 years, Therapeutics' Amortizatization of Intangibles (Yearly) stood at $497,000 in 2020, then crashed by 355.53% to -$1.3 million in 2021, then spiked by 123.31% to $296,000 in 2022, then soared by 1,837.84% to $5.7 million in 2023, then crashed by 50.96% to $2.8 million in 2024.